NodeAI Welcomes Prof. Kazuhiro Yasufuku as Advisor to the Board.

Ontario, Canada | October 2025 — NodeAI is proud to announce the appointment of Prof. Kazuhiro Yasufuku as an Advisor to the Board of Directors, marking a significant milestone in the company’s mission to revolutionize cancer diagnostics through artificial intelligence.

Prof. Yasufuku is a globally recognized leader in thoracic surgery and a pioneering innovator in the field of lung cancer diagnostics. He is best known as the co-inventor of the endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) procedure, an advancement that has fundamentally transformed the diagnosis and staging of lung cancer around the world.

He currently serves as Head of the Division of Thoracic Surgery and William Coco Chair in Surgical Innovation for Lung Cancer at the University Health Network (UHN). In addition, he holds leadership roles in numerous international societies for thoracic surgery and interventional pulmonology. His achievements have been recognized with prestigious honours, including the Japanese Medical Research and Development Grand Prize Award and the Sakura Award.

“NodeAI’s technology promises to augment EBUS-TBNA in a way that will revolutionize how we stage lung cancer. I am excited to be a part of this mission.”

— Prof. Kazuhiro Yasufuku

In his advisory role, Prof. Yasufuku will offer strategic guidance to the NodeAI leadership team, contributing deep expertise in lung cancer staging, surgical innovation, and minimally invasive diagnostics.

“Having Prof. Yasufuku, the inventor of EBUS, support and advise NodeAI is truly an honour and is a testament to the value our company brings to the field of lung cancer diagnostics.”

— Mackensey Bacon, CEO and Co-founder of NodeAI

As NodeAI continues to expand its team of clinicians, scientists, and technology leaders, the company remains focused on harnessing artificial intelligence to improve outcomes for cancer patients.

“Prof. Yasufuku has mentored generations of surgeons and endoscopists. Having him as an advisor is especially meaningful to me and to the thousands of lung cancer patients who have benefited from his care.”

— Dr. Wael Hanna, CMO and Co-founder of NodeAI

The addition of Prof. Yasufuku to NodeAI’s Board of Advisors marks a defining moment for the company, affirming its leadership at the intersection of clinical excellence and AI-powered innovation in cancer care.